Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| hydrochloorthiazide | Active Comparator | once a day 25 mg |
|
| placebo | Placebo Comparator | once a day placebo |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hydrochloorthiazide | Drug |
| ||
| placebo |
| Measure | Description | Time Frame |
|---|---|---|
| sodium level | a decrease of 5 mmol/L sodium in plama | 7 days |
| Measure | Description | Time Frame |
|---|---|---|
| time hypernatraemia | decrease of duration high sodium level in plasma | 7 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christiaan Boerma, MD | Frisius Medisch Centrum | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical Centre Leeuwarden | Leeuwarden | Provincie Friesland | 8801 AD | Netherlands |
Not provided
| ID | Term |
|---|---|
| D006955 | Hypernatremia |
| ID | Term |
|---|---|
| D014883 | Water-Electrolyte Imbalance |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|